Suppr超能文献

相似文献

1
Diagnosis and management of benign prostatic hyperplasia in primary care.
Can Urol Assoc J. 2009 Jun;3(3 Suppl 2):S92-S100. doi: 10.5489/cuaj.1116.
5
Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty.
Int J Clin Pract. 2008 Apr;62(4):614-22. doi: 10.1111/j.1742-1241.2008.01699.x. Epub 2008 Feb 8.
6
Management of symptomatic BPH in France: who is treated and how?
Eur Urol. 1999;36 Suppl 3:14-20. doi: 10.1159/000052344.

引用本文的文献

2
Bunge Ameliorates Benign Prostatic Hyperplasia through Regulation of Oxidative Stress via Nrf-2/HO-1 Activation.
J Microbiol Biotechnol. 2024 May 28;34(5):1059-1072. doi: 10.4014/jmb.2308.08053. Epub 2023 Oct 31.
3
Role of prostate stem cells and treatment strategies in benign prostate hyperplasia.
Am J Clin Exp Urol. 2022 Jun 15;10(3):154-169. eCollection 2022.
5
6
Drug-induced orthostatic hypotension: A systematic review and meta-analysis of randomised controlled trials.
PLoS Med. 2021 Nov 9;18(11):e1003821. doi: 10.1371/journal.pmed.1003821. eCollection 2021 Nov.
9
Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis.
Aging (Albany NY). 2020 Feb 4;12(3):2142-2155. doi: 10.18632/aging.102731.
10
MRI-based method for lower urinary tract dysfunction in adult male mice.
Am J Clin Exp Urol. 2019 Jun 15;7(3):153-158. eCollection 2019.

本文引用的文献

1
Serenoa repens for benign prostatic hyperplasia.
Cochrane Database Syst Rev. 2009 Apr 15(2):CD001423. doi: 10.1002/14651858.CD001423.pub2.
2
Uropharmacology for the primary care physician.
Can J Urol. 2008 Aug;15 Suppl 1:78-91; discussion 91.
4
Update on the diagnosis and management of prostate cancer.
Can J Urol. 2008 Aug;15 Suppl 1:3-13; discussion 13.
5
Improving therapeutic outcomes in BPH through diagnosis, treatment and patient compliance.
Am J Med. 2008 Aug;121(8 Suppl 2):S27-33. doi: 10.1016/j.amjmed.2008.05.024.
6
Benign prostatic hyperplasia: treat or wait?
J Fam Pract. 2008 Jul;57(7):454-63.
7
The REDUCE trial: chemoprevention in prostate cancer using a dual 5alpha-reductase inhibitor, dutasteride.
Expert Rev Anticancer Ther. 2008 Jul;8(7):1073-9. doi: 10.1586/14737140.8.7.1073.
9
Diagnosis and management of benign prostatic hyperplasia.
Am Fam Physician. 2008 May 15;77(10):1403-10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验